Reporting period: 2025-09-30 · Number of holdings: 1
Point72 Middle East FZE disclosed 1 holdings in its latest 13F filing for the period ending 2025-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Recent moves
Unchanged 000000000
$0.0
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
✓
Ikena Oncology INC
Stock-Other
—
—
—
Portfolio Performance
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 78% of reported portfolio value with available pricing
Position changes disclosed by Point72 Middle East FZE for the quarter ending 2025-09-30, including ticker, issuer, weight change, shares change, and action
What is Point72 Middle East FZE and what type of investor is it?
Point72 Middle East FZE is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2025-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Point72 Middle East FZE's largest equity positions?
Based on the latest 13F filing, Point72 Middle East FZE's top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Point72 Middle East FZE make in its most recent portfolio filing?
No notable portfolio changes were recorded for Point72 Middle East FZE in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Point72 Middle East FZE focus on?
Sector breakdown data is not yet available for Point72 Middle East FZE. Check back after the next 13F processing cycle.